EcoDrugPlus

Ensembl ID : ENSBMUG00000019153
Gene Symbol: -
Cross references: -
300 Possible Orthologues:

Ensembl ID : ENSBMUG00000023202
Gene Symbol: -
Cross references: -
179 Possible Orthologues:

Ensembl ID : ENSBMUG00000017637
Gene Symbol: -
Cross references: -
111 Possible Orthologues:

Ensembl ID : ENSBMUG00000014207
Gene Symbol: -
Cross references: -
155 Possible Orthologues:

Ensembl ID : ENSBMUG00000023268
Gene Symbol: -
Cross references: -
217 Possible Orthologues:

Ensembl ID : ENSBMUG00000020888
Gene Symbol: -
Cross references: -
113 Possible Orthologues:

Ensembl ID : ENSBMUG00000018540
Gene Symbol: -
Cross references: -
145 Possible Orthologues:

Ensembl ID : ENSBMUG00000013452
Gene Symbol: -
Cross references: -
74 Possible Orthologues:

Ensembl ID : ENSBMUG00000012795
Gene Symbol: -
Cross references: -
127 Possible Orthologues:

Ensembl ID : ENSBMUG00000025667
Gene Symbol: -
Cross references: -
196 Possible Orthologues:

Ensembl ID : ENSBMUG00000008481
Gene Symbol: -
Cross references: -
211 Possible Orthologues:

Ensembl ID : ENSBMUG00000007057
Gene Symbol: -
Cross references: -
277 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).